TP53 and invasive breast carcinoma: MDA-MB-231, a poorly differentiated, highly aggressive, and invasive breast cancer cell line, is a model representing triple-negative breast cancer, characterized by the lack of oestrogen receptor, progesterone receptor, E-cadherin, and HER2 growth factor receptor but presenting with mutated p53 gene expression [22, 23].